Literature DB >> 28983907

Rapid vasodilation to raloxifene: role of oestrogen receptors and off-target effects.

Matthias Barton1, Eric R Prossnitz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28983907      PMCID： PMC5660003          DOI： 10.1111/bph.14020

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  10 in total

1.  The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors.

Authors:  Stephen Ph Alexander; Anthony P Davenport; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

2.  Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases.

Authors:  E R Weidert; S O Schoenborn; N Cantu-Medellin; K V Choughule; J P Jones; E E Kelley
Journal:  Nitric Oxide       Date:  2014-01-07       Impact factor: 4.427

3.  The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

4.  Rapid vasodilation to raloxifene: role of oestrogen receptors and off-target effects.

Authors:  Matthias Barton; Eric R Prossnitz
Journal:  Br J Pharmacol       Date:  2017-10-06       Impact factor: 8.739

5.  Role of inducible nitric oxide synthase in endothelium-independent relaxation to raloxifene in rat aorta.

Authors:  Chi Ming Wong; Chak Leung Au; Suk Ying Tsang; Chi Wai Lau; Xiaoqiang Yao; Zongwei Cai; Arthur Chi-Kong Chung
Journal:  Br J Pharmacol       Date:  2017-02-27       Impact factor: 8.739

6.  Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780.

Authors:  Matthias R Meyer; Oliver Baretella; Eric R Prossnitz; Matthias Barton
Journal:  Pharmacology       Date:  2010-07-17       Impact factor: 2.547

7.  Identification of raloxifene as a novel CB2 inverse agonist.

Authors:  Pritesh Kumar; Zhao-Hui Song
Journal:  Biochem Biophys Res Commun       Date:  2013-04-20       Impact factor: 3.575

8.  CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.

Authors:  Paul L Prather; FeAna FrancisDevaraj; Centdrika R Dates; Aleksandra K Greer; Stacie M Bratton; Benjamin M Ford; Lirit N Franks; Anna Radominska-Pandya
Journal:  Biochem Biophys Res Commun       Date:  2013-10-19       Impact factor: 3.575

9.  The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors.

Authors:  Stephen Ph Alexander; John A Cidlowski; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971
  10 in total
  1 in total

1.  Rapid vasodilation to raloxifene: role of oestrogen receptors and off-target effects.

Authors:  Matthias Barton; Eric R Prossnitz
Journal:  Br J Pharmacol       Date:  2017-10-06       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.